Literature DB >> 26960791

An observational study assessing peripheral neuropathy related to multiple myeloma.

C Leone1, V Federico2, S La Cesa3, E Russo2, G Di Stefano3, P Finsinger2, R Labriola3, G Cruccu3, M T Petrucci2, A Truini3.   

Abstract

We aimed at assessing the prevalence of peripheral neuropathy in newly diagnosed, treatment-naïve patients with multiple myeloma. We enrolled 153 patients with multiple myeloma at initial diagnosis. All patients underwent neurological examination and nerve conduction study. Patients with suspected pure small fiber neuropathy underwent skin biopsy. Of the 153 patients included in this study, 7.2 % had a multiple myeloma-related neuropathy. All patients suffered from a distal symmetric sensory peripheral neuropathy, associated with age (P = 0.04). Our study on prevalence rate of multiple myeloma-related peripheral neuropathy might provide a basis for improving the clinical management of this condition.

Entities:  

Keywords:  Multiple myeloma; Polyneuropathy; Skin biopsy

Mesh:

Year:  2016        PMID: 26960791     DOI: 10.1007/s10072-016-2542-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

2.  Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain.

Authors:  L Padua; C Briani; A Truini; I Aprile; D Bouhassirà; G Cruccu; S Jann; E Nobile-Orazio; C Pazzaglia; A Morini; M Mondelli; P Ciaramitaro; G Cavaletti; D Cocito; R Fazio; L Santoro; F Galeotti; M Carpo; R Plasmati; L Benedetti; A Schenone
Journal:  Neurol Sci       Date:  2012-03-21       Impact factor: 3.307

Review 3.  Neurologic complications of acute and chronic renal disease.

Authors:  Martin W Baumgaertel; Markus Kraemer; Peter Berlit
Journal:  Handb Clin Neurol       Date:  2014

Review 4.  Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.

Authors:  Andreas A Argyriou; Gregoris Iconomou; Haralabos P Kalofonos
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

Review 5.  How to diagnose neuropathic pain? The contribution from clinical examination, pain questionnaires and diagnostic tests.

Authors:  S La Cesa; S Tamburin; V Tugnoli; G Sandrini; S Paolucci; M Lacerenza; P Marchettini; G Cruccu; A Truini
Journal:  Neurol Sci       Date:  2015-09-26       Impact factor: 3.307

6.  Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations.

Authors:  Raffaele Iorio; Mario Sabatelli; Alessandra Del Grande; Giulia Bisogni; Valentina Damato; Domenico Plantone; Alessandro Marti; Giovanni Frisullo; Angela Romano; Paolo Maria Rossini; Marco Luigetti
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

7.  The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Authors:  Guido Cavaletti; Barbara Frigeni; Francesca Lanzani; Marialuisa Piatti; Stefania Rota; Chiara Briani; Gabriella Zara; Rosaria Plasmati; Francesca Pastorelli; Augusto Caraceni; Andrea Pace; Mariagrazia Manicone; Andrea Lissoni; Nicoletta Colombo; Giulia Bianchi; Claudio Zanna
Journal:  J Peripher Nerv Syst       Date:  2007-09       Impact factor: 3.494

Review 8.  Review of peripheral neuropathy in plasma cell disorders.

Authors:  Jeannine Silberman; Sagar Lonial
Journal:  Hematol Oncol       Date:  2008-06       Impact factor: 5.271

9.  Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy.

Authors:  Vinay Chaudhry; David R Cornblath; Michael Polydefkis; Anna Ferguson; Ivan Borrello
Journal:  J Peripher Nerv Syst       Date:  2008-12       Impact factor: 3.494

10.  Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.

Authors:  Debra A Howell; Fiona Warburton; Amanda-Jane Ramirez; Eve Roman; Alexandra G Smith; Lindsay J L Forbes
Journal:  Br J Cancer       Date:  2015-09-01       Impact factor: 7.640

View more
  3 in total

1.  Baseline peripheral neuropathy was associated with age and a prognostic factor in newly diagnosed multiple myeloma patients.

Authors:  Mengmeng Dong; Jinna Zhang; Xiaoyan Han; Jingsong He; Gaofeng Zheng; Zhen Cai
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

2.  Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.

Authors:  Yoshiki Nakae; Mizuki Hyuga; Yuta Terada; Wataru Kishimoto; Akiko Fukunaga; Sumie Tabata; Yoshitomo Maesako; Kenichi Komatsu; Osamu Higuchi; Toshinari Nakane; Nobuyoshi Arima
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

3.  High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study.

Authors:  B E Oortgiesen; J A Kroes; P Scholtens; J Hoogland; P Dannenberg-de Keijzer; C Siemes; F G A Jansman; R E Kibbelaar; N J G M Veeger; M Hoogendoorn; E N van Roon
Journal:  Support Care Cancer       Date:  2021-07-17       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.